APA (7th ed.) Citation

M, B., S, M., M, Y., M, H., F, H., D, K., & A, D. (2023). Effect of metformin (vs. placebo or sulfonylurea) on all-cause and cardiovascular mortality and incident cardiovascular events in patients with diabetes: An umbrella review of systematic reviews with meta-analysis. Journal of diabetes and metabolic disorders, 23(1), 27. https://doi.org/10.1007/s40200-023-01309-y

Chicago Style (17th ed.) Citation

M, Bahardoust, Mousavi S, Yariali M, Haghmoradi M, Hadaegh F, Khalili D, and Delpisheh A. "Effect of Metformin (vs. Placebo or Sulfonylurea) on All-cause and Cardiovascular Mortality and Incident Cardiovascular Events in Patients with Diabetes: An Umbrella Review of Systematic Reviews with Meta-analysis." Journal of Diabetes and Metabolic Disorders 23, no. 1 (2023): 27. https://doi.org/10.1007/s40200-023-01309-y.

MLA (9th ed.) Citation

M, Bahardoust, et al. "Effect of Metformin (vs. Placebo or Sulfonylurea) on All-cause and Cardiovascular Mortality and Incident Cardiovascular Events in Patients with Diabetes: An Umbrella Review of Systematic Reviews with Meta-analysis." Journal of Diabetes and Metabolic Disorders, vol. 23, no. 1, 2023, p. 27, https://doi.org/10.1007/s40200-023-01309-y.